Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Stocks
MIDEAST STOCKS-Saudi bourse falls on Trump tariff plan; Qatar gains
By Ateeq Shariff Feb 2 (Reuters) - Saudi Arabia's stock market ended lower on Sunday after U.S. President Donald Trump announced tariffs on Canada, Mexico and China, while the Qatari index gained ahead of several corporate earnings statements.The U.S. tariffs may impact the Gulf region's ...
Reuters
Feb 2, 2025
Stocks
1 Top Risk the Smartest Investors Know About SoFi Stock
SoFi Technologies (NASDAQ: SOFI) has been kind to its investors. In the past 12 months, shares have more than doubled. The fintech stock still trades 38% below its peak from February 2021. And when you look at the latest financial results, there are reasons investors should be optimistic.Where to in...
The Motley Fool
Feb 2, 2025
Stocks
3 Smart EV Stocks to Buy With $1,000 Right Now
Many electric car stocks had a difficult 2024. Industrywide growth fell below initial expectations, with some EV stocks falling in value by 50% or more. But the long-term growth trajectory of EV demand remains intact.So if you have $1,000 with you that you won't require for essential spending, and a...
The Motley Fool
Feb 2, 2025
Stocks
AST SpaceMobile Investors: Prepare to Be Diluted
I hate to say I told you so (but I did). And just as I forewarned back in September, AST SpaceMobile (NASDAQ: ASTS) stock has decided to dilute its investors.Again.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 s...
The Motley Fool
Feb 2, 2025
Stocks
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic fibrosis (CF). Last Thursday, the agency approved Vertex's Journavx in treating adults with modera...
The Motley Fool
Feb 2, 2025
Stocks
Carnival Stock Is Up 75%. Is It Time to Sell?
Carnival (NYSE: CCL) (NYSE: CUK) finished 2024 in a solid financial position. It reported record revenue and returned to profitability, and the stock responded by climbing 75% over the last 12 months. Investors who bought the stock a year ago might be tempted to take profits, but there's tremendous ...
The Motley Fool
Feb 2, 2025
Stocks
With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?
Over the past six months, Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, it is still a bit surprising, since the pharmaceutical giant is one of the undisputed leaders in the exciting market for weight loss drugs.It turns ou...
The Motley Fool
Feb 2, 2025
Economic Indicator
Australian home prices flatlined in January - CoreLogic
SYDNEY, Feb 3 (Reuters) - Australia's home prices flatlined in January as weakness in the major cities offset gains in the countryside, data showed on Monday, while the mounting chance of a near-term cut in interest rates could provide some support to demand over time.Figures from property consu...
Reuters
Feb 2, 2025
Other
Israel's Netanyahu heads for Washington to renew connection with Trump
Netanyahu seeks to reset relations with USTrump administration expected to support Israeli settlementsNetanyahu balances US ties with coalition pressures Recasts and writes through with further detail and contextBy James Mackenzie JERUSALEM, Feb 2 (Reuters) - Prime Minister Benjamin Netanyahu lef...
Reuters
Feb 2, 2025
Stocks
Meta Platforms' Revenue Jumps as It Plans to Invest Big in AI. Is the Stock a Buy?
Meta Platforms' (NASDAQ: META) share price rose after the social media company released strong fourth-quarter results, once again showing that its social media sites are top destinations for both users and advertisers. The company also remained committed to spending big on artificial intelligence (A...
The Motley Fool
Feb 2, 2025
Stocks
1 Glorious Reason Warren Buffett Would Appreciate Netflix Stock
Netflix (NASDAQ: NFLX) continues to be a winning bet for investors. Shares are up 70% just in the past 12 months. And they have soared 1,420% in the past decade, crushing the performance of the S&P 500.Warren Buffett, the legendary investor who is the longtime CEO of Berkshire Hathaway, is familiar ...
The Motley Fool
Feb 2, 2025
Other
Turkey hopes Trump will end US cooperation with Syrian Kurdish militia
Recasts with Turkish foreign minister's comments DOHA/ISTANBUL, Feb 2 (Reuters) - Turkish Foreign Minister Hakan Fidan said on Sunday he hoped President Donald Trump would end U.S. cooperation with the Syrian Kurdish YPG, as Turkey continued its military campaign against the group, killing 23...
Reuters
Feb 2, 2025
Stocks
If You'd Invested $5,000 in Innovative Industrial Properties Stock in 2018, Here's How Much You'd Have Today
Innovative Industrial Properties (NYSE: IIPR) is a standout among marijuana stocks. Unlike a great many other publicly traded companies in the weed industry, the cannabis-focused real estate investment trust's (REIT) shares have actually appreciated in price over the years. In fact, they've grown co...
The Motley Fool
Feb 2, 2025
Stocks
With New Glenn Rocket a Success, Blue Origin's Next Step Is to Build a $100 Billion Orbital Reef
The International Space Station (ISS) has given America a home in space for the last 27 years. Sometime after 2030, though, America plans to lock the doors on ISS, hand in the keys, and send it plunging into the sea. But this won't be the end of America's orbital adventures. Long before ISS takes it...
The Motley Fool
Feb 2, 2025
Stocks
ExxonMobil Dominated Last Year, Delivering 1 of Its Best Performances of the Past 10 Years
ExxonMobil (NYSE: XOM) is a powerhouse in the oil patch. The oil giant delivered an industry-leading financial performance last year, producing over $33 billion in earnings and $55 billion in cash flow from operations. That was its third-best performance over the past decade.What's remarkable about ...
The Motley Fool
Feb 2, 2025
Cryptocurrencies
XRP Posts Highest Monthly Close Ever—What’s Next?
XRP has ushered in 2025 with a robust bullish performance, achieving its highest monthly close to date. As a result of significant advancements in regulation and institutional adoption, the token’s surge coincides with a growing sense of optimism in the broader crypto market. XRP advanced towa...
NewsBTC
Feb 2, 2025
Cryptocurrencies
Bitcoin Keeps Bullish Momentum Without Overheating – Indicators Show Room For Further Growth
Bitcoin is facing serious selling pressure, as it has dropped below the $100K mark, raising concerns about a potential deeper correction. Since mid-January, BTC has been trading sideways, fluctuating between all-time highs (ATH) and the $97,750 level, struggling to find a clear direction. Related Re...
Bitcoinist
Feb 2, 2025
Stocks
3 Tech and AI Stocks That Just Blew the Cover Off of Earnings
With earnings season now in full swing, investors and analysts are carefully monitoring the results, particularly on high-flying tech and artificial intelligence stocks trading at rich valuations and after the emergence of DeepSeek, which rocked the sector.Most publicly traded companies report their...
The Motley Fool
Feb 2, 2025
Stocks
3 Reasons Why Warren Buffett Should Buy Chipotle Stock Hand Over Fist, and 1 Reason Why He Might Regret It
Warren Buffett is certainly familiar with the restaurant industry. Berkshire Hathaway, the conglomerate he has been running for decades, owns Dairy Queen. And it has previously owned Restaurant Brands International.I think the Oracle of Omaha likes the durability of these businesses. After all, peop...
The Motley Fool
Feb 2, 2025
Other
RPT-Trump stretches trade law boundaries with Canada, Mexico, China tariffs
Repeats story published earlier, no change to textIEEPA statute widely used for sanctions, untested for tariffsCourts have long deferred to US presidents on emergenciesTariff medicine may be too strong for fentanyl, migrant crisis, lawyer says By David Lawder WASHINGTON, Feb 1 (Reuters) - Preside...
Reuters
Feb 2, 2025
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free